Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Psychotic Disorders

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Psychotic Disorders in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wierońska, JM1
Acher, FC1
Sławińska, A1
Gruca, P1
Lasoń-Tyburkiewicz, M1
Papp, M1
Pilc, A1
Gartside, SE1
Johnson, DA1
Leitch, MM1
Troakes, C1
Ingram, CD1

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Psychotic Disorders

ArticleYear
The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.
    Psychopharmacology, 2013, Volume: 227, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Aminobutyrates; Amphetamines; Animals; Antipsychotic Agents;

2013
Early life adversity programs changes in central 5-HT neuronal function in adulthood.
    The European journal of neuroscience, 2003, Volume: 17, Issue:11

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Analysis of Variance; Animals; An

2003